Latest Business and People News
Updated employee announcements, business news, awards and recognition in the industry today.
People NewsOmniComm Systems announced that current president and Chief Operating Officer, Stephen Johnson, will be name Chief Executive Officer in place of current CEO Cornelius Wilt. Wilt will remain with the company as Executive Chairman. Additionally, OmniComm Head of Development, Keith Howells will be named as Chief Technology Officer in place of company founder, Chairman of the Board and current CTO Randall Smith. Smith will also remain with the company as Executive Vice Chairman.
Industry veteran George Masoura has joined Drug Dev as Vice President, Business Development, Europe.
ClinActis announced Bill Van Nostrand as Head of Business Development, North America. Van Nostrand is the founder of late-stage CRO, InVivo.
TFS has appointed Dr. Bassem Saleh as Chief Medical Officer and Ed Tumaian as VP Global Clinical Development. Saleh and Tumaian will both also join the Operational Leadership Team.
Worldwide Clinical Trials has appointed William Hirschman as Executive Vice President and Head of Global Business Development.
INC Research has appointed the following experts to their Real World & Late Phase and Global Consulting teams: Dr. James Featherstone as Senior Vice President of Strategy Consulting, Janet Baldwin as Vice President of Real World & Late Phase and Head of North America Operations, Nathalie Doize as Vice President, Real World & Late Phase and Head of Europe and Asia/Pacific Operations and Alastair MacDonald as Executive Director, Real World & Late Phase.
RecognitionRho announced that Jack Modell, MD, Vice President and Senior Medical Officer, was named as a board member for the Carolinas Chapter of the National Diversity Council (NDC). The NDC is a national non-partisan nonprofit organization dedicated to providing resources and advocacy for the value of diversity and inclusion.
ERT has received the Omega Management Group Corporation’s NorthFace ScoreBoard (NFSB) Award for achieving excellence in customer satisfaction for the fifth consecutive year.
goBalto has been selected by CIOReview as one of the 20 Most Promising Biotech Technology Solution Providers for the second consecutive year.
The International Society for CNS Drug Development (ISCDD) celebrated its 15th anniversary at the ISCDD 2017 Annual Meeting.
Rho has been named as a winner in the inaugural Corporate Philanthropy Awards by the Triangle Business Journal.
ICON plc has been awarded “Best Clinical Research Organization” at the Vaccine Industry Excellence Awards.
SimpleTrials has been recognized as one of the Top 10 eClinical Trial Management Solution Providers for 2017 by Pharma Tech Outlook Magazine.
Business NewsDrug Dev expanded the adoptions of its DrugDev Spark clinical operations suite in Europe.
Drug Dev announces an industry milestone of over $2 billion processed to sites on behalf of sponsors and CROs worldwide.
ACI Clinical has surpassed a new milestone of 50,000 adjudicated endpoints during the first quarter of 2017.
BioPlan Associates has released its updated textbook, A Quick Guide to Clinical Trials, 2nd Edition, which describes the clinical trials process and drug development from an international perspective.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
